2020 ended with over 15% positive returns for investors. After AstraZeneca-Oxford vaccine Covishield got a nod from the Indian regulators, there is a sense of optimism in the public, investors and market participants. However, the domestic and global economic recovery is still a work in progress. - While FPIs (foreign portfolio investors) can afford to take risks, many feel they are sensitive to interest rates outside. - India will have to showcase the speed of its vaccination programme and the effectiveness of the vaccine as that will provide confidence to the masses, corporates and foreign investors.

Source: dna January 01, 2021 12:11 UTC